Regulatory Insights

  1. Accelerating Milestones And Reducing Regulatory Risk 12/10/2025

    Modern adaptive Phase 1 oncology trials speed timelines, refine dosing, and meet FDA standards, replacing outdated 3+3 methods to boost efficiency, safety, and regulatory success.

  2. Why Multi-Omic Insights Demand A Multi-Omic Strategy 12/10/2025

    Gene therapy development faces complex scientific and regulatory challenges. Success requires optimized vectors, robust preclinical studies, biomarker strategies, and coordinated FDA engagement.

  3. Gene Therapy & CDx: Smarter Development 12/10/2025

    Gene therapy success depends on optimized vectors, robust trials, biomarker-driven strategies, and coordinated regulatory planning for companion diagnostics and FDA engagement.

  4. Should Sponsors Provide Source Document Templates? 12/9/2025

    Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.

  5. New ICH GCP Changes Center The Patient 12/8/2025

    Explore key changes to the guidelines and how they're transforming clinical trials with a focus on patient centricity, digital innovation, and risk-based quality management.

  6. FDA Guidance On Payment And Reimbursement To Research Subjects 12/5/2025

    Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.

  7. Does 'The Belmont Report' Provide Guidance For Patient Stipends? 12/5/2025

    Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.

  8. Navigating The AI And Regulatory Frontier For Clinical Operations, Supply 12/5/2025

    AI is transforming clinical trials. Learn how strategic adoption and cultural readiness can unlock efficiency, resilience, and compliance in an evolving global landscape.

  9. Regulatory Comparisons For Starting First-In-Human Clinical Trials 12/4/2025

    Engage early with regulatory and clinical experts to navigate evolving global requirements and ensure your first-in-human strategy supports downstream development and multinational approvals.

  10. How Mobile Clinics Advance Diversity In Clinical Research 12/4/2025

    Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.